Home / Glossary

GLP-1 glossary

Plain-English definitions of terms you'll see in GLP-1 guides, labels and provider sites.

Advertiser disclosure: We may earn a commission from links on this page, at no cost to you. Affiliate disclosure.

Not medical advice: This is general information. Talk to your doctor before starting, stopping or changing any medication. Medical disclaimer.

BMI
Body mass index: weight in kilograms divided by height in meters squared. FDA labels for weight-management GLP-1s use BMI thresholds of 30, or 27 with a weight-related condition.
Boxed warning
The FDA's strongest label warning. Wegovy, Ozempic and Zepbound carry one about thyroid C-cell tumors seen in rodent studies.
Compounded drug
A medication mixed by a pharmacy rather than made by the brand manufacturer. Compounded GLP-1s are not FDA-approved and are not equivalent to brand-name medicines.
503A pharmacy
A state-licensed compounding pharmacy that prepares medications for individual patients with a prescription.
503B outsourcing facility
A larger compounding facility registered with the FDA. In 2025 the FDA ended enforcement discretion for 503B compounding of semaglutide and tirzepatide.
GIP
Glucose-dependent insulinotropic polypeptide, a gut hormone. Tirzepatide acts on both GIP and GLP-1 receptors.
GLP-1
Glucagon-like peptide-1, a gut hormone that affects appetite, stomach emptying and blood sugar. GLP-1 receptor agonists mimic it.
Manufacturer-direct pharmacy
A self-pay pharmacy run by or for the drug maker, such as LillyDirect or NovoCare Pharmacy.
MASH
Metabolic dysfunction-associated steatohepatitis, a form of fatty liver disease. Wegovy has accelerated approval for certain adults with noncirrhotic MASH.
Off-label use
Prescribing an approved drug for a use not listed on its label, such as Ozempic for weight loss alone.
Orforglipron
The active ingredient in Foundayo, a small-molecule GLP-1 drug taken as a daily pill.
Prior authorization
An insurer's requirement to approve a medication before it will pay for it.
Semaglutide
A GLP-1 receptor agonist; the active ingredient in Wegovy, Ozempic and the Wegovy pill.
Telehealth
Healthcare delivered remotely, by questionnaire, messaging or video, by a licensed clinician.
Tirzepatide
A GIP and GLP-1 receptor agonist; the active ingredient in Zepbound and Mounjaro.
Titration
Increasing a medication's dose gradually, usually every few weeks, to reduce side effects.

See also: GLP-1 medications · All guides

GLP1Rated is for general information only and is not medical advice. GLP-1 medications are prescription drugs with real risks and side effects. Talk to a licensed clinician before starting, stopping or changing any medication or supplement.

The GLP-1 brief

Price drops, new approvals and provider changes, once a week. No spam, unsubscribe any time.